Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

People with Alopecia Areata are more likely to have prediabetes and obesity.

COVID-19 vaccines do not increase the risk of alopecia areata.

UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Hypothyroidism may cause certain types of hair loss.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

hsa-miR-193a-5p may help diagnose and treat alopecia areata.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Alopecia areata costs individuals about 3% of their income, with women, Asians, those with lower income, and more severe symptoms spending more.

Tiny particles improved delivery of hair loss treatments to hair follicles, with lipid-based particles performing best.